Overview

Treatment of Zollinger-Ellison Syndrome With Prevacid

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study the safety and efficacy of high dose Prevacid in the long-term treatment of patients who secrete abnormally large amounts of gastric acid.
Phase:
Phase 4
Details
Lead Sponsor:
Charles Mel Wilcox, MD
Collaborator:
Takeda Pharmaceuticals North America, Inc.
Treatments:
Dexlansoprazole
Lansoprazole